Fulphila 6 MG/0.6 ML syringe 0.6ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9PJ6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,452
Award facts
- Contract value 100% obligated
- $14,452.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp (Cencora, Inc.) on February 4, 2026, for the supply of Fulphila 6 mg/0.6 mL syringes valued at $14,452.39 with a firm fixed-price structure. This non-set-aside award represents a competitive procurement of pharmaceutical products to support federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, the headquarters location of the prime contractor, with an ultimate completion date of February 5, 2026.
This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc., maintains an even larger IDC with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies supporting military healthcare programs worldwide. Through this arrangement, AmerisourceBergen supplies an extensive range of pharmaceutical commodities including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9PJ6?
SPE2DR26F9PJ6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F9PJ6 worth?
The government has obligated $14,452 on SPE2DR26F9PJ6.
Is contract SPE2DR26F9PJ6 an order under another contract?
Yes. SPE2DR26F9PJ6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9PJ6 competed?
The extent of competition for SPE2DR26F9PJ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award